NCT03723928 2026-04-02S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerSWOG Cancer Research NetworkPhase NA Recruiting739 enrolled